Poc@Unipd 2022

Poc@Unipd 2022

With the aim of supporting the competitiveness of businesses by enhancing industrial properties, the Ministry for Economic Development (MISE) has published a call for the establishment of patent enhancement programs, through funding of Proof of Concept (PoC) projects by Italian Universities, Public Research Institutions (EPR), and Scientific Institutions for Research, Hospital and Healthcare (IRCS).

Purpose of the call is establishing TRL (Technology Readiness Level) enhancement paths for technologies patented during academic research, and create the conditions to turn them into strategic opportunities for the business world.

After careful examination of the project proposals received by the Ministry Evaluation Committee, the University of Padua was authorized to develop 8 PoC projects. The projects were selected by the University through an internal call and the program took the first steps in December 2023. From that moment on, the PoC Team started to work to validate the relevant technologies.

The academic work team has been flanked by an external Expert Committee, comprising top scientific and professional resources (investors and entrepreneurs), capable of providing a respected standpoint on all strategic and planning choices.

UniSMART – Fondazione Università di Padova was tasked with managing the enhancement of the results of 8 projects, through its highly qualified, innovation-oriented staff, in the different PoC project sectors.

PROGETTO PoC@UNIPD2022 – PNRR – Missione 1, Componente 2, Investimento 6 – finanziato dall’Unione Europea – NextGenerationEU

PoC@Unipd project 2022

  • CO2 SUP & HPMAP+ – Innovative technologies for the preservation and safety of food and biomedical products

    The technologies developed by the University of Padua exploit pressurized carbon dioxide (CO₂) for the treatment of packaged products, with the aim of reducing microbial load while preserving the quality, structure, and sensory properties of treated materials. The first patent,...

  • CuRE – Copper complexes as novel anticancer agents

    Although platinum-based drugs, such as cisplatin, have achieved great success in cancer treatment and are presently enclosed in the majority of clinical protocols for the management of solid malignancies, their use are associated with significant drawbacks such as severe toxic...

  • INSERT – SerpinB3 inhibitor for tumor treatment

    Expression of SerpinB3, a member of serine-protease inhibitor family, is associated with the carcinogenesis process as it determines resistance to apoptosis, induces cell proliferation and greater cell invasiveness. Furthermore, it leads to impaired immune surveillance and reduced chemosensitivity. Recent studies...

  • MERCURIO – Communication system based on multipole-phase division

    The patent discloses a spatial division multiplexing optical communication system comprising optical devices for the multiplexing and demultiplexing of beams endowed with different multipole phases. This invention proposes an innovative and efficient solution to increase the transmission capacity of the...

  • RAPID-AFM1 – Rapid detection of Aflatoxin M1 in milk

    The present invention relates to a method and a device useful for directly and rapidly quantifying the presence in milk of Aflatoxin M1, a carcinogenic mycotoxin deriving from Aflatoxin B1. In particular conditions of humidity or high temperatures, some vegetable...

  • siRNAEEC – Novel treatment to mitigate the Ectrodactyly-Ectodermal dysplasia- Clefting (EEC) associated blindness

    The Ectrodactyly-Ectodermal dysplasia-Clefting (EEC) syndrome is a rare genetic disorder due to mutations in the p63 gene and characterized by limb defects, orofacial clefting, ectodermal dysplasia, and ocular surface defects that lead to the loss of vision. Currently no specific...

  • TEC-PROMEST – Protein extraction method for diagnostics

    Accurate diagnosis and typing of Amyloidosis, a group of diseases where the abnormal protein, called amyloid, builds-up in the organs and interferes with their normal function, is of paramount importance in order to determine the appropriate therapeutic intervention. Current methods...

  • TREM2MICROENGINES – Novel Regulated Promoter for Gene Therapy

    Neuroinflammation, characterized by microglial cell-activation, plays a major role in the pathogenesis and progression of multiple neurodegenerative diseases, such as Lysosomal Storage Disorders and Alzheimer’s, severe human conditions currently lacking an effective treatment. Ex vivo gene therapy based on genetically...

How can we help you?

Contact our team to understand how to get access to the resources of the University of Padua, and start a collaboration in line with your needs.